COYA - CIK 0001835022
Coya Therapeutics, Inc. (COYA) reported net income of -$21.23M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$21.23M | -42.6% |
| FY 2024 | -$14.88M | -86.3% |
| FY 2023 | -$7.99M | +34.8% |
| FY 2022 | -$12.24M | -150.3% |
| FY 2021 | -$4.89M | - |
Coya Therapeutics, Inc. (COYA) reported net income of -$21.23M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2021 and fiscal 2025, Coya Therapeutics, Inc.'s net income declined from -$4.89M to -$21.23M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.